Recent Antitrust Lessons For The Life Sciences Industry

By Eric Grannon, Rebecca Farrington and Adam Acosta (October 25, 2019, 1:57 PM EDT) -- The life sciences industry continues to face a steady flow of government and private plaintiff antitrust investigations and lawsuits, which at times has resulted in billion-dollar government fines, injunctive relief and class-wide damages. A common theme among these antitrust investigations and lawsuits is the use of internal company documents as some of the most damaging evidence. ...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!